COYA-301

N/A

Report date: 2025/04/16 16:57:01

Base Information

Drug NameCOYA-301
Drug Alias NameLD IL-2Low-dose IL-2COYA-301
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionRegulatory T-lymphocytes stimulantsInterleukin-2 replacements
TargetsInterleukin-2
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCoya Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCoya Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A